硬脑膜淀粉样瘤的FDG PET/CT表现一例
一例49岁女性因反复眩晕1个月就诊,MRI示右侧额部凸面硬脑膜增厚并明显强化,部分切除后病理证实为硬脑膜淀粉样瘤,患者未接受进一步治疗。随访FDG PET/CT显示残留硬脑膜淀粉样瘤FDG摄取增高,提示硬脑膜淀粉样瘤应纳入硬脑膜病变FDG异常摄取的鉴别诊断。
要点
- 硬脑膜淀粉样瘤可表现为硬脑膜局限性增厚并明显强化。
- 残留硬脑膜淀粉样瘤在随访FDG PET/CT上可表现为FDG摄取增高。
- 硬脑膜病变FDG异常摄取鉴别诊断时应考虑硬脑膜淀粉样瘤。
核心结论
- 本病例提示硬脑膜淀粉样瘤应纳入硬脑膜病变FDG异常摄取的鉴别诊断。
研究设计与样本
- 个案报道:1例49岁女性,反复眩晕1个月,经部分切除病理证实为硬脑膜淀粉样瘤,未接受进一步治疗,行随访FDG PET/CT。
主要发现
- 治疗前MRI示右侧额部凸面硬脑膜增厚,信号强度与白质相似,增强T1加权像示病灶明显强化。
- 部分切除病灶后病理证实为硬脑膜淀粉样瘤,患者未接受进一步治疗。
- 随访FDG PET/CT示残留硬脑膜淀粉样瘤FDG摄取增高。
临床怎么用
- 原文未报告具体临床处理推荐,仅提示硬脑膜病变FDG异常摄取鉴别诊断时应考虑硬脑膜淀粉样瘤。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dural amyloidoma is an unusual presentation of central nervous system amyloidosis. A 49-year-old woman presented with 1-month history of repeated episodes of vertigo. Precontrast MRI showed dural thickening over right frontal convexity with signal intensity similar to white matter. Postcontrast T1-weighted images showed remarkable enhancement of the lesion. Dural amyloidoma was confirmed by partial resection of the lesion. The patient underwent no further treatment. A follow-up FDG PET/CT showed increased FDG uptake of the residual dural amyloidoma. This case indicates dural amyloidoma should be included in the differential diagnosis of abnormal FDG uptake in dural lesions.
引用
- Ran P, Liu Y, Liang X, et al. FDG PET/CT in a Case of Dural Amyloidoma. Clin Nucl Med. 2018. PMID: 30300204. doi:10.1097/RLU.0000000000002304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。